Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Brain Neoplasms × Methotrexate × 30 days × Clear all

Sponsor

Conditions

Burkitt Lymphoma 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Leukemia, Biphenotypic, Acute 5 Lymphoma 3 Leukemia, Myeloid, Acute 3 Urinary Bladder Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Osteosarcoma 2 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2 Shwachman-Diamond Syndrome 1 Rhabdoid Tumor 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Recurrence 1 Primary Myelofibrosis 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Multiple Myeloma 1 Meningeal Neoplasms 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Monocytic, Acute 1 Leukemia, Lymphoid 1 Leukemia 1 Hydatidiform Mole 1 Hemoglobinuria, Paroxysmal 1 Gestational Trophoblastic Disease 1 Down Syndrome 1 Congenital amegakaryocytic thrombocytopenia 1

Interventions

Radiosurgery 12 Magnetic Resonance Spectroscopy 8 Temozolomide 7 Bevacizumab 6 Specimen Handling 5 trastuzumab deruxtecan 4 pembrolizumab 4 Radiotherapy 4 Nivolumab 4 Cyclophosphamide 4 Biopsy 4 abemaciclib 3 Ipilimumab 3 entrectinib 2 cabozantinib 2 Trastuzumab 2 Surveys and Questionnaires 2 Surgical Procedures, Operative 2 Sirolimus 2 Receptors, Interleukin-8B 2 Mental Status and Dementia Tests 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Dexamethasone 2 Adrenal Cortex Hormones 2 trastuzumab biosimilar HLX02 1 temsirolimus 1 ribociclib 1 repotrectinib 1 regorafenib 1 pertuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡